Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

68Ga-FAPI PET/CT to Detect Ongoing Fibroblast Activity in Post-acute COVID-19 With Respiratory Impairment After Hospital Discharge

NCT05981885 is registered in ClinicalTrials.gov with University Medical Center Groningen as lead sponsor.

NCT NCT05981885
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05981885 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
68Ga-FAPI PET/CT to Detect Ongoing Fibroblast Activity in Post-acute COVID-19 With Respiratory Impairment After Hospital Discharge
Lead sponsor
University Medical Center Groningen
Phase
Observational
Overall status
Completed
Start date
June 9, 2022
Completion date
May 17, 2024
Enrollment
18 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

post-acute covid-19, post-acute covid-19 infection, post-acute covid-19 syndrome, pulmonary fibrosis